Results 181 to 190 of about 15,400,316 (399)

Classification of large circulating tumor cells isolated with ultra-high throughput microfluidic Vortex technology

open access: diamond, 2016
James Che   +15 more
openalex   +2 more sources

A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing

open access: yesScience, 2018
D. Pan   +16 more
semanticscholar   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

VEGFR-1 Expressed by Malignant Melanoma-Initiating Cells Is Required for Tumor Growth

open access: green, 2011
Natasha Y. Frank   +13 more
openalex   +2 more sources

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2002
Yoshiko Iwai   +5 more
semanticscholar   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

Preoperative C-reactive protein is related with renal cell tumor dimension? Preliminary results [PDF]

open access: diamond, 2023
Adelina Miron   +6 more
openalex   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy